-
Teva’s Budeprion XL Will Get Another Safety And Efficacy Review By FDA
FDA To Collaborate With Complaining Patients On Study Of Reported Problems With This Generic Version Of Antidepressant Wellbutrin XL (Posted by Tom Lamb at DrugInjuryWatch.com) By means of a September 23, 2008 Wall Street…
-
Association Between Long Term Fosamax Use And Femoral Stress Fracture Is Challenged
September 2008 ASBMR Meeting: Dr. Abrahamsen Asserts Atypical Fractures Of Femur Are Not Triggered By Fosamax (Posted by Tom Lamb at DrugInjuryWatch.com) In late June 2008 we learned that one type of femoral stress…
-
FDA: Tequin Was Withdrawn From U.S. Market “For Reasons Of Safety Or Effectiveness”
Recall That Bristol-Myers Had Said Decline In Sales Was Reason For Its Decision To Stop Selling Tequin (Posted by Tom Lamb at DrugInjuryWatch.com) On September 2, 2008 the FDA issued a Notice entitled "Determination…
-
New Reports Of Vytorin And Zetia Causing Liver Failure And Liver Disease
2008 Medical Journal Articles Describe Two Cases; Authors Suggest Liver Testing At Start Of Therapy And When Titrating Dosage Is Necessary (Posted by Tom Lamb at DrugInjuryWatch.com) In December 2007 we told you about an…
-
Do You Want To Sign The “FDA Preemption = Bad Medicine” Online Petition?
This Petition Is Sponsored By A Group Of Concerned Citizens Called "Americans for Drug and Device Accountability" (Posted by Tom Lamb at DrugInjuryWatch.com) In several earlier posts I have advocated that any application of…
-
August 2008: NuvaRing MDL Created In Federal Court System, Eastern District Of Missouri
Ruling By Judicial Panel on Multidistrict Litigation Will Result In Transfer Of All NuvaRing Federal Court Cases (Posted by Tom Lamb at DrugInjuryWatch.com) ____________________________________________________________________ UPDATE: Our Focus Page on NuvaRing has a complete collection…
